The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
Bosch Packaging Technology has announced plans to sell its packaging machinery business.
“After intensively and thoroughly considering all its strategic options, the Bosch Group has decided to look for a buyer for its packaging machinery business...
Boehringer Ingelheim (BI) has completed a new filling line at its commercial manufacturing facility in Shanghai, China for its contract manufacturing business, BioXcellence. The new isolator-based fill/finish line is for GMP operations for aseptic...
Catalent has agreed to acquire Juniper Pharmaceuticals, a Boston, Massachusetts-headquartered specialty pharmaceutical company with contract development and manufacturing services, including its Nottingham, UK-based Juniper Pharma Services...
General Electric (GE) has announced plans to spin off GE Healthcare, its healthcare business, as a stand-alone company, following results from a strategic review. The plan is part of a larger reorganization and strategic alignment of the company....
WuXi Biologics, part of WuXi AppTec, a Shanghai, China-headquartered contract service provider, has begun construction of an antibody-drug conjugate (ADC) service center in Wuxi, China.
The $20-million 6,000-square-meter facility will be...
MilliporeSigma has signed an agreement with HistoCyte Laboratories, a Tyne, UK-based cell-line technology company, to be the exclusive multinational distributor of HistoCyte’s portfolio of cell-line reference products for immunohistochemistry and...
Minakem, the contract development and manufacturing division of Minafin, a Mont-Saint-Guibert, Belgium-based fine chemicals producer, plans to open a new closed-controlled environment high-containment production facility in August 2018 at the...
Marken, a Research Triangle Park, North Carolina-based provider of logistics and supply-chain services for clinical trial materials, is relocating its Chicago logistics hub into a new, larger facility near the Chicago airport.
The new full-service...
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has divested its rights, except in the US, for a potassium iodide product, ThyroSafe, to SERB SA, a Brussels, Belgium-headquartered specialty pharmaceutical...
Sarepta Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company focused on RNA-targeted therapeutics for rare neuromuscular diseases, has formed a long-term manufacturing partnership for gene-therapy with Brammer Bio, a Lexington,...
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has agreed to acquire Sanofi’s contract manufacturing business for respiratory products in Holmes Chapel, England for approximately $60 million.
The business...
Thermo Fisher Scientific has opened a US Precision Medicine Science Center (PMSC) in Cambridge, Massachusetts. The center offers access to technologies to help collaborators develop analytical workflows that generate precise molecular profiles of...
AMRI, a contract research, development, and manufacturing organization, has signed a seven-year contract with the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to manufacture active...
WuXi Biologics, part of WuXi AppTec, a Shanghai, China-headquartered contract service provider, plans to invest $60 million to establish a biologics clinical and commercial manufacturing facility in Worcester, Massachusetts. The facility will be...
Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), plans to expand research and development (R&D) capabilities at its site in Paullo, Milan, Italy.
The company is...
